Press release
Histone Deacetylase (HDAC) Inhibitors - Pipeline Insights 2017
Histone Deacetylase (HDAC) Inhibitors - Pipeline Insights 2017
View report: https://www.arizton.com/reports/pharma-pipeline-analysis/histone-deacetylase-hdac-inhibitors-pipeline-insights
The report profiles key players in developing potential HDAC drug candidates. The company profile section provides details such as company overview, business overview, financial overview, product portfolio, business strategies, and recent developments.
Related Reports
1) Tumor Necrosis Factor Alpha (TNF-a) Inhibitors - Pipeline Insights 2017
https://www.arizton.com/reports/pharma-pipeline-analysis/tumor-necrosis-factor-alpha-tnf-a-inhibitors-pipeline-insights
2) Chimeric Antigen Receptor (CAR) T Cell Immunotherapy - Pipeline Insights 2017
https://www.arizton.com/reports/pharma-pipeline-analysis/chimeric-antigen-receptor-car-t-cell-immunotherapy-pipeline-insights-2017
About Arizton
Arizton – Advisory and Intelligence is an innovation and quality-driven firm, which offers cutting-edge research solutions to clients across the world. We excel in providing comprehensive market intelligence reports and advisory and consulting services.
Arizton has gained a paramount standpoint in the market research arena as it offers top of the line solutions to clients to assess market landscape and to finalize foolproof business strategies. We are committed to provide inclusive market research reports and consulting services to clients from diversified industries including –Consumer Goods & Retail Technology, Automotive and Mobility, Smart Tech, Healthcare and Lifesciences, Industrial Machinery, Chemicals and Materials, IT and Media, Logistics and Packaging
Arizton comprises a team of exuberant and well-experienced analysts who have mastered in generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.
Arizton Advisory & Intelligence
Chicago, Illinois, 60605
Mail: enquiry@arizton.com
Call: +1-312-465-7864
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Histone Deacetylase (HDAC) Inhibitors - Pipeline Insights 2017 here
News-ID: 785399 • Views: …
More Releases from Arizton Advisory & Intelligence
Europe Data Center Colocation Market Investment to Reach USD 46.51 Billion by 20 …
Europe Data Center Colocation Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2026-2031
According to recent research by Arizton, the Europe data center colocation market by investment was valued at USD 11.65 billion in 2025 and is expected to reach USD 46.51 billion by 2031, growing at a CAGR of 25.94%. Western Europe is expected to account for approximately USD 33.17 billion, representing 71.3% of…
Global Precision Parts Market Size to Reach USD 376.96 Billion by 2031, with APA …
Precision Parts Market Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2026-2031.
According to recent research by Arizton, the global precision parts market was valued at USD 264.82 billion in 2025 and is expected to reach USD 376.96 billion by 2031, growing at a CAGR of 6.06% during the forecast period. Market growth is being driven by rising aerospace and defense manufacturing investments, advancements in precision…
Hong Kong Data Center Colocation Market Size to Reach USD 2.75 Billion by 2031 - …
Insights on 56 Existing Colocation Data Center Facilities and 15 Upcoming Facilities across Hong Kong
According to recent research by Arizton, the Hong Kong data center colocation market was valued at USD 1.57 billion in 2025 and is expected to reach USD 2.75 billion by 2031, growing at a CAGR of 9.79% during the forecast period. Hong Kong is strengthening its position as a key destination for colocation investment, with around…
Global Board Games Market Size to Be Worth USD 39.46 Billion by 2031, Growing at …
Board Games Market Size, Share & Growth Forecast 2026-2031
According to Arizton the global board games market size was valued at USD 21.5 billion in 2025 and is expected to reach USD 39.46 billion by 2031, growing at a CAGR of 10.65% during the forecast period. Growth is being supported by broader demand across family, social, educational, collectible, and hobby-led formats, with gifting, licensed titles, expansion content, cafés, and organized play…
More Releases for HDAC
Key Factor Supporting Global Histone Deacetylase (HDAC) Inhibitors Market Develo …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Histone Deacetylase (HDAC) Inhibitors Market Size By 2025?
The valuation of the histone deacetylase (hdac) inhibitors market has seen considerable expansion lately, projected to advance from $1.23 billion in 2024 to reach $1.32 billion by 2025, reflecting a consistent annual growth rate of 7.6% over…
Rising Neurodegenerative Disorders Drive Growth In HDAC Inhibitors Market: Pivot …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Histone Deacetylase (HDAC) Inhibitors Market Size Growth Forecast: What to Expect by 2025?
The market for histone deacetylase (HDAC) inhibitors has seen substantial growth in the last few years. The market is predicted to expand from a size of $1.23 billion in 2024 to $1.33 billion in 2025, with…
HDAC Inhibitors Market Projected to Grow Significantly Through 2034 | DelveInsig …
The HDAC Inhibitors companies in the market include - Merck & Co., Bristol Myers Squibb, Celgene Corporation, Spectrum Pharmaceuticals, and Syndax Pharmaceuticals, among others.
The HDAC inhibitor market has shown significant growth in recent years, driven by the increasing prevalence of several key indications commonly treated with HDAC inhibitors, growing research in epigenetics, and expanding applications beyond oncology. According to DelveInsight's comprehensive analysis, key pharmaceutical companies, including Merck & Co., Bristol…
Key Trend Reshaping the Histone Deacetylase (HDAC) Inhibitors Market in 2025: Sh …
Which drivers are expected to have the greatest impact on the over the histone deacetylase (hdac) inhibitors market's growth?
The increasing incidence of neurodegenerative diseases is expected to drive the growth of the histone deacetylase (HDAC) inhibitors market. Neurodegenerative disorders, such as Alzheimer's disease, involve the progressive degeneration of neurons, leading to cognitive and motor dysfunction. The rising prevalence of these disorders is due to aging, genetics, and environmental factors. HDAC…
Histone Deacetylase (HDAC) Inhibitors Market 2022 | Detailed Report
The Histone Deacetylase (HDAC) Inhibitors research report undoubtedly meets the strategic and specific needs of the businesses and companies. The report acts as a perfect window that provides an explanation of market classification, market definition, applications, market trends, and engagement. The competitive landscape is studied here in terms of product range, strategies, and prospects of the market's key players. Furthermore, the report offers insightful market data and information about the…
HDAC Inhibitors Market - Increasing R&D activities for cancer is expected to boo …
Overview
HDAC inhibitors are a kind of anti-cancer drug that works by causing cell cycle arrest, apoptosis, and death in cancer cells through non-epigenetic or epigenetic control. HDAC inhibitors (HDACi) are potential medicines that have already demonstrated promise in oncological applications such as cancer detection, treatment, and prognostic. Vorinostat (Merck & Co. Inc.) is a new medication that is used to treat epidermal T cell lymphoma as it progresses, relapses, or…
